Our finding that TGFβ can induce mesenchymal transition provides another secretory factor that is able to trigger mesenchymal differentiation in GBM, thus contributing to tumor heterogeneity and enhanced tumor aggressiveness. The gene discussed is TGFB1; the disease is glioblastoma.